Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer.
Sakaeda K, Kurose K, Matsumura Y, Muto S, Fukuda M, Sugasaki N, Fukuda M, Takemoto S, Taniguchi H, Masuda T, Shimizu K, Kataoka Y, Irino Y, Sakai Y, Atarashi Y, Yanagida M, Hattori N, Mukae H, Nakata M, Kanda E, Oga T, Suzuki H, Oka M. Sakaeda K, et al. Among authors: taniguchi h. Cancer Treat Res Commun. 2024;40:100830. doi: 10.1016/j.ctarc.2024.100830. Epub 2024 Jun 28. Cancer Treat Res Commun. 2024. PMID: 38964205 Free article.
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
Shimada M, Taniguchi H, Yamaguchi H, Gyotoku H, Sasaki D, Kaku N, Senju C, Senju H, Imamura E, Takemoto S, Yamamoto K, Sakamoto N, Obase Y, Tsuchiya T, Fukuda M, Soda H, Ashizawa K, Fukuoka J, Nagayasu T, Yanagihara K, Mukae H. Shimada M, et al. Among authors: taniguchi h. Transl Lung Cancer Res. 2023 Apr 28;12(4):707-718. doi: 10.21037/tlcr-22-794. Epub 2023 Mar 23. Transl Lung Cancer Res. 2023. PMID: 37197618 Free PMC article.
Role of CD38 in anti-tumor immunity of small cell lung cancer.
Taniguchi H, Chavan SS, Chow A, Chan JM, Mukae H, Rudin CM, Sen T. Taniguchi H, et al. Front Immunol. 2024 Mar 12;15:1348982. doi: 10.3389/fimmu.2024.1348982. eCollection 2024. Front Immunol. 2024. PMID: 38533509 Free PMC article.
Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients.
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. Hata T, et al. Among authors: taniguchi h. Lung Cancer. 2025 Jan 25;200:108104. doi: 10.1016/j.lungcan.2025.108104. Online ahead of print. Lung Cancer. 2025. PMID: 39889466
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. Hata T, et al. Among authors: taniguchi h. Clin Lung Cancer. 2025 Jan 4:S1525-7304(25)00001-4. doi: 10.1016/j.cllc.2025.01.002. Online ahead of print. Clin Lung Cancer. 2025. PMID: 39864962
RNase T2 deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells.
Sato R, Liu K, Shibata T, Hoshino K, Yamaguchi K, Miyazaki T, Hiranuma R, Fukui R, Motoi Y, Fukuda-Ohta Y, Zhang Y, Reuter T, Ishida Y, Kondo T, Chiba T, Asahara H, Taoka M, Yamauchi Y, Isobe T, Kaisho T, Furukawa Y, Latz E, Nakatani K, Izumi Y, Nie Y, Taniguchi H, Miyake K. Sato R, et al. Among authors: taniguchi h. J Exp Med. 2025 Mar 3;222(3):e20230647. doi: 10.1084/jem.20230647. Epub 2025 Jan 24. J Exp Med. 2025. PMID: 39853307 Free PMC article.
2,988 results